Anabolic Steroid Control Act of 2004
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
June 3, 2004
View full timeline
Introduced in House
March 1, 2004
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
March 1, 2004
Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
March 11, 2004
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
March 12, 2004
Subcommittee Hearings Held.
March 16, 2004
Subcommittee Consideration and Mark-up Session Held.
March 30, 2004
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.
March 30, 2004
Mr. Boehner asked unanimous consent that the Committee on Judiciary have until midnight on April 2 to file a report on H.R. 3866. Agreed to without objection.
April 2, 2004
Reported (Amended) by the Committee on Judiciary. H. Rept. 108-461, Part I.
April 2, 2004
House Committee on Energy and Commerce Granted an extension for further consideration ending not later than April 27, 2004.
April 2, 2004
Committee Consideration and Mark-up Session Held.
April 22, 2004
Ordered to be Reported (Amended) by Voice Vote.
April 22, 2004
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 108-461, Part II.
April 27, 2004
Placed on the Union Calendar, Calendar No. 270.
April 27, 2004
Mr. Sensenbrenner moved to suspend the rules and pass the bill, as amended.
June 2, 2004 • 3:21 PM
Considered under suspension of the rules. (consideration: CR H3660-3665)
June 2, 2004 • 3:21 PM
DEBATE - The House proceeded with forty minutes of debate on H.R. 3866.
June 2, 2004 • 3:21 PM
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
June 2, 2004 • 3:43 PM
Considered as unfinished business. (consideration: CR H3740-3741)
June 3, 2004 • 1:01 PM
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 408 - 3 (Roll no. 226).(text: CR 6/2/2004 H3660-3661)
June 3, 2004 • 1:09 PM
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 408 - 3 (Roll no. 226). (text: CR 6/2/2004 H3660-3661)
June 3, 2004 • 1:09 PM
Motion to reconsider laid on the table Agreed to without objection.
June 3, 2004 • 1:09 PM
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
June 3, 2004
Voting History
1 vote recorded • Roll call available
Floor Debate
23 membersWhat members said about H.R. 3866 on the floor




+18
Floor Debate
23 membersWhat members said about H.R. 3866 on the floor
Mr. Speaker, pursuant to House Resolution 656, I call up the bill (H.R. 444) to amend the Workforce Investment Act of 1998 to establish a Personal Reemployment Accounts grant program to assist…
Mr. Speaker, I rise in strong opposition to H.R. 444, and I yield myself such time as I may consume. Mr. Speaker, this bill completely misses the mark. American workers need job creation. American…
Mr. Speaker, I thank the chairman for yielding me this time. This is a big day for me personally because this is a piece of legislation that represents an agreement on a piece of legislation that I…
Mr. Speaker, I rise in strong support of H.R. 444 for multiple reasons. First of all, we are facing an ever-changing economy both nationally and internationally. Could you imagine just a few years…
Mr. Speaker, I thank the gentleman from Michigan (Mr. Kildee) very much for the time, and it is a pleasure to work with him on the committee to protect the rights of workers and also to speak to the…
Show 8 more
Mr. Speaker, I thank the gentleman for yielding and for his handling of this bill for the minority on the floor and his work on it in the committee. And the gentleman from Michigan (Mr. Kildee) is…
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3866) to amend the Controlled Substances Act to provide increased penalties for anabolic steroid offenses near sports facilities, and…
Yes, Mr. Speaker. Mr. Speaker, I yield 3 minutes to the gentleman from Georgia (Mr. Isakson), the vice-chairman of the Subcommittee on 21st Century Competitiveness. Mr. Speaker, I thank the gentleman…
Mr. Speaker, I thank the gentleman from Michigan (Mr. Kildee) for yielding me time, and I thank him for his work in opposition to this bill. I think he has it exactly right, Mr. Speaker. These PRAs,…
Mr. Speaker, let me thank the gentleman from Michigan (Mr. Kildee) for his leadership on this issue and helping working people in our country; and, Mr. Speaker, let me say I wish that the comments of…
Mr. Speaker, it is about time we address unemployment. Unfortunately, H.R. 444 is not the legislation that will truly put Americans back to work. It offers only a temporary solution for a limited…
Mr. Speaker, I rise today in support of the Anabolic Steroid Control Act, H.R. 3866, and commend my colleagues from the Committee on the Judiciary and Committee on Energy and Commerce for their hard…
Mr. Speaker, I rise today in opposition to H.R. 444, the so-called the ``Back to Work Incentive Act.'' This bill is based on flawed assumptions and is an insult to the 1.8 million Americans--22…
Show 11 more
Mr. Speaker, I thank the gentleman from California (Mr. McKeon) for yielding me time. I thank the gentleman from Nevada (Mr. Porter) for his work on this. The discussion I have just heard was about…
Mr. Speaker, this bill would establish a demonstration project that would ostensibly offer personal reemployment accounts to workers, providing up to $3,000 in assistance for the purpose of finding a…
Mr. Speaker, I would like to thank the gentleman from Wisconsin (Mr. Sensenbrenner) and the gentleman from Texas (Mr. Barton) for advancing this legislation. I would particularly like to thank the…
Mr. Speaker, today we are voting on a bill that will limit access to most steroids. In principle, this is a good thing and, in general, I support this bill. However, this legislation is flawed. While…
Mr. Speaker, I strongly support the legislative proposal under consideration today. Without a doubt, H.R. 3866, the ``Anabolic Steroid Control Act of 2004,'' represents a major step in the right…
Mr. Speaker, it seems that in these debates we so often get sidetracked into discussions of ideology, and I think it is important we focus on the bill before us. I certainly have great respect for…
Mr. Speaker, I thank my friend, the gentleman from Michigan (Mr. Kildee), for yielding me time. I rise in opposition to the bill. I suppose if you are one of the 8 million unemployed Americans…
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 3866, the Anabolic Steroid Control Act of 2004. This legislation updates the ban on steroids to include…
Mr. Speaker, I thank the gentleman from Ohio (Mr. Boehner) for his leadership as chairman on the Committee on Education and the Workforce. He is doing a tremendous job. I also want to thank the…
Mr. Speaker, I urge my colleagues to vote for the Kildee motion to recommit H.R. 444. This motion does what is needed. The real problems that our country faces today are a lack of jobs and a lack of…
Mr. Speaker, I would welcome a constructive approach to help people who are struggling with the consequences of long-term unemployment. For nearly three years now, Oregon has had one of the highest…
Bill Text
4 versions available
[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3866 Engrossed in House (EH)]
108th CONGRESS
2d Session
H. R. 3866
_______________________________________________________________________
AN ACT
To amend the Controlled Substances Act to provide increased penalties
for anabolic steroid offenses near sports facilities, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Anabolic Steroid Control Act of
2004''.
SEC. 2. INCREASED PENALTIES FOR ANABOLIC STEROID OFFENSES NEAR SPORTS
FACILITIES.
(a) In General.--Part D of the Controlled Substances Act is amended
by adding at the end the following:
anabolic steroid offenses near sports facilities
``Sec. 424. (a) Whoever violates section 401(a)(1) or section 416
by manufacturing, distributing, or possessing with intent to
distribute, an anabolic steroid near or at a sports facility is subject
to twice the maximum term of imprisonment, maximum fine, and maximum
term of supervised release otherwise provided by section 401 for that
offense.
``(b) As used in this section--
``(1) the term `sports facility' means real property where
athletic sports or athletic training takes place, if such
property is privately owned for commercial purposes or if such
property is publicly owned, but does not include any real
property described in section 419;
``(2) the term `near or at' means in or on, or within 1000
feet of; and
``(3) the term `possessing with intent to distribute' means
possessing with the intent to distribute near or at a sports
facility.''.
(b) Table of Contents Amendment.--The table of contents for
Comprehensive Drug Abuse Prevention and Control Act of 1970 is amended
by inserting after the item relating to section 423 the following new
item:
``Sec. 424. Anabolic steroid offenses near sports facilities.''.
SEC. 3. SENTENCING COMMISSION GUIDELINES.
The United States Sentencing Commission shall--
(1) review the Federal sentencing guidelines with respect
to offenses involving anabolic steroids;
(2) consider amending the Federal sentencing guidelines to
provide for increased penalties with respect to offenses
involving anabolic steroids in a manner that reflects the
seriousness of such offenses and the need to deter anabolic
steroid use; and
(3) take such other action that the Commission considers
necessary to carry out this section.
SEC. 4. AMENDMENTS TO THE CONTROLLED SUBSTANCES ACT.
(a) Definitions.--Section 102 of the Controlled Substances Act (21
U.S.C. 802) is amended--
(1) in paragraph (41)--
(A) by realigning the margin so as to align with
paragraph (40); and
(B) by striking subparagraph (A) and inserting the
following:
``(A) The term `anabolic steroid' means any drug or hormonal
substance, chemically and pharmacologically related to testosterone
(other than estrogens, progestins, corticosteroids, and
dehydroepiandrosterone), and includes--
``(i) androstanediol--
``(I) 3b,17b-dihydroxy-5a-androstane; and
``(II) 3a,17b-dihydroxy-5a-androstane;
``(ii) androstanedione (5a-androstan-3,17-dione);
``(iii) androstenediol--
``(I) 1-androstenediol (3b,17b-dihydroxy-5a-
androst-1-ene);
``(II) 1-androstenediol (3a,17b-dihydroxy-5a-
androst-1-ene);
``(III) 4-androstenediol (3b,17b-dihydroxy-androst-
4-ene); and
``(IV) 5-androstenediol (3b,17b-dihydroxy-androst-
5-ene);
``(iv) androstenedione--
``(I) 1-androstenedione ([5a]-androst-1-en-3,17-
dione);
``(II) 4-androstenedione (androst-4-en-3,17-dione);
and
``(III) 5-androstenedione (androst-5-en-3,17-
dione);
``(v) bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-
3-one);
``(vi) boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
``(vii) calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-
en-3-one);
``(viii) clostebol (4-chloro-17b-hydroxyandrost-4-en-3-
one);
``(ix) dehydrochlormethyltestosterone (4-chloro-17b-
hydroxy-17a-methylandrost-1,4-dien-3-one);
``(x) D1-dihydrotestosterone (also known as 1-testosterone)
(17b-hydroxy-5a-androst-1-en-3-one);
``(xi) 4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
``(xii) drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-
one);
``(xiii) ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
``(xiv) fluoxymesterone (9-fluoro-17a-methyl-11b,17b-
dihydroxyandrost-4-en-3-one);
``(xv) formebolone (2-formyl-17a-methyl-11a,17b-
dihydroxyandrost-1,4-dien-3-one);
``(xvi) furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-
furazan);
``(xvii) 13a-ethyl-17b-hydroxygon-4-en-3-one;
``(xviii) 4-hydroxytestosterone (4,17b-dihydroxy-androst-4-
en-3-one);
``(xix) 4-hydroxy-19-nortestosterone (4,17b-dihydroxy-estr-
4-en-3-one);
``(xx) mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-
one);
``(xxi) mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-
3-one);
``(xxii) methandienone (17a-methyl-17b-hydroxyandrost-1,4-
dien-3-one);
``(xxiii) methandriol (17a-methyl-3b,17b-dihydroxyandrost-
5-ene);
``(xxiv) methenolone (1-methyl-17b-hydroxy-5a-androst-1-en-
3-one);
``(xxv) methyltestosterone (17a-methyl-17b-hydroxyandrost-
4-en-3-one);
``(xxvi) mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-
3-one);
``(xxvii) 17a-methyl-D1-dihydrotestosterone (17 b-hydroxy-
17a-methyl-5a-androst-1-en-3-one) (also known as `17-a-methyl-
1-testosterone');
``(xxviii) nandrolone (17b-hydroxyestr-4-en-3-one);
``(xxix) norandrostenediol--
``(I) 19-nor-4-androstenediol (3b, 17b-
dihydroxyestr-4-ene);
``(II) 19-nor-4-androstenediol (3a, 17b-
dihydroxyestr-4-ene);
``(III) 19-nor-5-androstenediol (3b, 17b-
dihydroxyestr-5-ene); and
``(IV) 19-nor-5-androstenediol (3a, 17b-
dihydroxyestr-5-ene);
``(xxx) norandrostenedione--
``(I) 19-nor-4-androstenedione (estr-4-en-3,17-
dione); and
``(II) 19-nor-5-androstenedione (estr-5-en-3,17-
dione);
``(xxxi) norbolethone (13b,17a-diethyl-17b-hydroxygon-4-en-
3-one);
``(xxxii) norclostebol (4-chloro-17b-hydroxyestr-4-en-3-
one);
``(xxxiii) norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-
3-one);
``(xxxiv) oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-
androstan-3-one);
``(xxxv) oxymesterone (17a-methyl-4,17b-dihydroxyandrost-4-
en-3-one);
``(xxxvi) oxymetholone (17a-methyl-2-hydroxymethylene-17b-
hydroxy-[5a]-androstan-3-one);
``(xxxvii) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-
2-eno[3,2-c]-pyrazole);
``(xxxviii) stenbolone (17b-hydroxy-2-methyl-[5a]-androst-
1-en-3-one);
``(xxxix) testolactone (13-hydroxy-3-oxo-13,17-
secoandrosta-1,4-dien-17-oic acid lactone);
``(xl) testosterone (17b-hydroxyandrost-4-en-3-one);
``(xli) tetrahydrogestrinone (13b,17a-diethyl-17b-
hydroxygon-4,9,11-trien-3-one);
``(xlii) trenbolone (17b-hydroxyestr-4,9,11-trien-3-one);
and
``(xliii) any salt, ester, or ether of a drug or substance
described in this paragraph;''; and
(2) in paragraph (44), by inserting ``anabolic steroids,''
after ``marihuana,''.
(b) Authority and Criteria for Classification.--Section 201(g) of
the Controlled Substances Act (21 U.S.C. 811(g)) is amended--
(1) in paragraph (1), by striking ``substance from a
schedule if such substance'' and inserting ``drug which
contains a controlled substance from the application of titles
II and III of the Comprehensive Drug Abuse Prevention and
Control Act (21 U.S.C. 802 et seq.) if such drug''; and
(2) in paragraph (3), by adding at the end the following:
``(C) Upon the recommendation of the Secretary of Health
and Human Services, a compound, mixture, or preparation which
contains any anabolic steroid, which is intended for
administration to a human being or an animal, and which,
because of its concentration, preparation, formulation or
delivery system, does not present any significant potential for
abuse.''.
(c) Anabolic Steroids Control Act.--Section 1903 of the Anabolic
Steroids Control Act of 1990 (Public Law 101-647; 21 U.S.C. 802 note)
is amended--
(1) by striking subsection (a); and
(2) by redesignating subsections (b) and (c) as subsections
(a) and (b), respectively.
SEC. 5. REPORTING REQUIREMENT.
Not later than 2 years after the date of the enactment of this Act,
the Secretary of Health and Human Services, in consultation with the
Attorney General, shall prepare and submit a report to the Judiciary
Committee of the House and Senate, and to the Committee on Energy and
Commerce of the House, evaluating the health risks associated with
dietary supplements not scheduled under the amendments made by this Act
which contain substances similar to those added to the list of
controlled substances under those amendments. The report shall include
recommendations on whether such substances should be regulated as
anabolic steroids.
Passed the House of Representatives June 3, 2004.
Attest:
Clerk.
108th CONGRESS
2d Session
H. R. 3866
_______________________________________________________________________
AN ACT
To amend the Controlled Substances Act to provide increased penalties
for anabolic steroid offenses near sports facilities, and for other
purposes.